Anidulafungin
Brand names: ERAXIS
Therapeutic Indications
Anidulafungin is indicated for:
Invasive candidiasis
Irrespective of gender only Adults (18 years old or older)
Treatment of invasive candidiasis in adult patients.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 100-200 mg once daily
Contraindications
Active ingredient Anidulafungin is contraindicated in the following cases: